BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18704993)

  • 1. Predictors of patient preferences and treatment choices for localized prostate cancer.
    Sommers BD; Beard CJ; D'Amico AV; Kaplan I; Richie JP; Zeckhauser RJ
    Cancer; 2008 Oct; 113(8):2058-67. PubMed ID: 18704993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decision analysis using individual patient preferences to determine optimal treatment for localized prostate cancer.
    Sommers BD; Beard CJ; D'Amico AV; Dahl D; Kaplan I; Richie JP; Zeckhauser RJ
    Cancer; 2007 Nov; 110(10):2210-7. PubMed ID: 17893907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of preferences and utilities in men treated with 3D-CRT for prostate cancer.
    Bruner DW; Hanlon A; Mazzoni S; Raysor S; Konski A; Hanks G; Pollack A
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):34-42. PubMed ID: 14697418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eliciting patient preferences for hormonal therapy options in the treatment of metastatic prostate cancer.
    Lloyd A; Penson D; Dewilde S; Kleinman L
    Prostate Cancer Prostatic Dis; 2008; 11(2):153-9. PubMed ID: 17637761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physician Recommendations Trump Patient Preferences in Prostate Cancer Treatment Decisions.
    Scherr KA; Fagerlin A; Hofer T; Scherer LD; Holmes-Rovner M; Williamson LD; Kahn VC; Montgomery JS; Greene KL; Zhang B; Ubel PA
    Med Decis Making; 2017 Jan; 37(1):56-69. PubMed ID: 27510740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating preferences for treatments in patients with localized prostate cancer.
    Ávila M; Becerra V; Guedea F; Suárez JF; Fernandez P; Macías V; Mariño A; Hervás A; Herruzo I; Ortiz MJ; Ponce de León J; Sancho G; Cunillera O; Pardo Y; Cots F; Ferrer M;
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):277-87. PubMed ID: 25491504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personal preferences and discordant prostate cancer treatment choice in an intervention trial of men newly diagnosed with localized prostate cancer.
    Bosco JL; Halpenny B; Berry DL
    Health Qual Life Outcomes; 2012 Sep; 10():123. PubMed ID: 23021156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commentary on: "Satisfaction with information used to choose prostate cancer treatment." Gilbert SM, Sanda MG, Dunn RL, Greenfield TK, Hembroff L, Klein E, Saigal CS, Pisters L, Michalski J, Sandler HM, Litwin MS, Wei JT. H. Lee Moffitt Cancer Center, Tampa, Florida; Department of Urology, Emory University, Atlanta, Georgia; Department of Urology, University of Michigan, Ann Arbor, Michigan; Department of Psychiatry and Public Health Institute, University of California-San Francisco, California; Institute for Public Policy and Social Research, Michigan State University, Lansing, Michigan; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio; Department of Urology and Department of Health Policy and Management, University of California-Los Angeles, Los Angeles, California; Department of Urology, University of Texas M.D. Anderson Cancer Center, Houston, Texas; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri; Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, California.: J Urol 2014;191(5):1265-71. doi:10.1016/j.juro.2013.12.008. [Epub 2013 Dec 12].
    Brent H
    Urol Oncol; 2016 May; 34(5):247-8. PubMed ID: 25990613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients' preferences for communicating a prostate cancer diagnosis and participating in medical decision-making.
    Davison BJ; Parker PA; Goldenberg SL
    BJU Int; 2004 Jan; 93(1):47-51. PubMed ID: 14678366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regret in men treated for localized prostate cancer.
    Hu JC; Kwan L; Saigal CS; Litwin MS
    J Urol; 2003 Jun; 169(6):2279-83. PubMed ID: 12771770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How older patients' treatment preferences are influenced by disclosures about therapeutic uncertainty: surgery versus expectant management for localized prostate cancer.
    Mazur DJ; Merz JF
    J Am Geriatr Soc; 1996 Aug; 44(8):934-7. PubMed ID: 8708303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient treatment preferences in localized prostate carcinoma: The influence of emotion, misconception, and anecdote.
    Denberg TD; Melhado TV; Steiner JF
    Cancer; 2006 Aug; 107(3):620-30. PubMed ID: 16802287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry.
    Punnen S; Cowan JE; Chan JM; Carroll PR; Cooperberg MR
    Eur Urol; 2015 Oct; 68(4):600-8. PubMed ID: 25242555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient experiences at diagnosis and psychological well-being in prostate cancer: A Finnish national survey.
    Lehto US; Helander S; Taari K; Aromaa A
    Eur J Oncol Nurs; 2015 Jun; 19(3):220-9. PubMed ID: 25547457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients' perceptions of the negative effects following different prostate cancer treatments and the impact on psychological well-being: a nationwide survey.
    Lehto US; Tenhola H; Taari K; Aromaa A
    Br J Cancer; 2017 Mar; 116(7):864-873. PubMed ID: 28222069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urodynamics tests for the diagnosis and management of bladder outlet obstruction in men: the UPSTREAM non-inferiority RCT.
    Lewis AL; Young GJ; Selman LE; Rice C; Clement C; Ochieng CA; Abrams P; Blair PS; Chapple C; Glazener CM; Horwood J; McGrath JS; Noble S; Taylor GT; Lane JA; Drake MJ
    Health Technol Assess; 2020 Sep; 24(42):1-122. PubMed ID: 32902375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients' satisfaction with different modalities of prostate cancer therapy--a retrospective survey among 634 patients.
    Wagner W; Bölling T; Hambruegge C; Hartlapp J; Krukemeyer MG
    Anticancer Res; 2011 Nov; 31(11):3903-8. PubMed ID: 22110217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life and treatment outcomes: prostate carcinoma patients' perspectives after prostatectomy or radiation therapy.
    Shrader-Bogen CL; Kjellberg JL; McPherson CP; Murray CL
    Cancer; 1997 May; 79(10):1977-86. PubMed ID: 9149026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of complications other than urinary incontinence or erectile dysfunction after radical prostatectomy or radiotherapy for prostate cancer: a population-based cohort study.
    Nam RK; Cheung P; Herschorn S; Saskin R; Su J; Klotz LH; Chang M; Kulkarni GS; Lee Y; Kodama RT; Narod SA
    Lancet Oncol; 2014 Feb; 15(2):223-31. PubMed ID: 24440474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doctors' and patients' preferences for participation and treatment in curative prostate cancer radiotherapy.
    Stalmeier PF; van Tol-Geerdink JJ; van Lin EN; Schimmel E; Huizenga H; van Daal WA; Leer JW
    J Clin Oncol; 2007 Jul; 25(21):3096-100. PubMed ID: 17634489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.